sing cardiac magnetic resonance imaging to detect early changes in heart muscle that may help predict patients who are at risk of developing toxicity from anthracycline chemotherapy.
Not Applicable
Recruiting
- Conditions
- Anthracycline chemotherapy induced cardiac toxicityLymphomaCardiovascular - Other cardiovascular diseasesCancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphomaCancer - Lymphoma (non Hodgkin's lymphoma) - Low grade lymphoma
- Registration Number
- ACTRN12612001100886
- Lead Sponsor
- Dr James Hare
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patient referred for anthracycline chemotherapy (i.e. for lymphoma)
Healthy controls
Exclusion Criteria
1. Acute renal failure or chronic renal failure manifest by GFR<60 ml/kg/1.73m2.
2. Contraindication to MRI scanning.
3. Known hypersensitivity to gadolinium.
4. Atrial fibrillation at baseline.
5. Pregnancy.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method